Certara stock.

PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the …Nov 21, 2023 · About Certara Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,300 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at Certara.com. Certara Contact: The estimated Net Worth of William F Feehery is at least $64.1 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $30,975,471 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Presentation Operator MessageOperator Good day, and thank you for standing by. Welcome to the Certara Third Quarter 2023 Earnings Conference Call. [Operator Instructions] ... Stock Certara, Inc. - Nasdaq . News Certara, Inc. Transcript : Certara, Inc., Q3 2023 Earnings Call, Nov 08, 2023. CATEGORIES. Indexes; Equities ...Drayton Virkler CERT stock SEC Form 4 insiders trading. Drayton has made over 2 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Drayton exercised 3,990 units of CERT stock worth $54,863 on 31 March 2023.3,990 units of CERT stock worth $54,863 on 31 March 2023.

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing. 144: 0001959173-23-003878.pdf. 0001959173-23-003878.rtf. View HTML: Aug 23, 2023: Statement of changes in beneficial ownership of securities. 4: 0001415889-23-012566.pdf. ... Please find the Certara ...Oct 11, 2023 · PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8 th , 2023. Certara is the leading provider of mechanistic modeling software and consulting services, predicting outcomes for the global biopharm industry. The groundbreaking Simcyp Simulator is relied upon by pharmaceutical and biotech companies, academia and regulatory agencies, including the US FDA. Simcyp is committed to using technology and innovation ...

Inclisiran is a novel N-acetylgalactosamine (GalNAc) conjugated small-interfering ribonucleic acid (siRNA) therapy designed to specifically target proprotein convertase subtilisin/kexin type 9 (PCSK9) mRNA in the liver for the treatment of hypercholesterolemia.

Get Certara alerts: Insider Activity at Certara. In other Certara news, major shareholder Avatar Parent L.P. Eqt sold 1,500,000 shares of the company's stock in a transaction dated Tuesday, May 31st. The stock was sold at an average price of $19.00, for a total value of $28,500,000.00.PRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced it has successfully supported 300 completed submissions to ...Patrick Smith CERT stock SEC Form 4 insiders trading. Patrick has made over 6 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Patrick sold 19,104 units of CERT stock worth $411,691 on 5 June 2023.. The largest trade Patrick's ever made was selling 19,104 units of Certara stock on 5 June …

Shares of Certara, Inc. (NASDAQ:CERT – Get Free Report) have earned an average recommendation of “Hold” from the eight research firms that are currently covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 …

With Certara, Inc. shares trading a bit north of 30 times earnings and nearly 6.5 times forward sales, there is nothing compelling about the stock's current valuation given Certara's projected ...

Overall, BILL Holdings Inc stock has a Value Score of 9, Growth Score of 69 and Momentum Score of 41. Certara Inc stock has a Value Score of 11, Growth Score of 50 and Momentum Score of 48. Comparing BILL Holdings Inc and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.The estimated net worth of Robert Aspbury is at least $5.51 million as of June 14th, 2021. Dr. Aspbury owns 375,451 shares of Certara stock worth more than $5,511,621 as of November 28th. This net worth estimate does not reflect any other investments that Dr. Aspbury may own.Certara Stock Performance. Certara stock opened at $14.71 on Tuesday. The stock’s 50 day moving average price is $13.73 and its 200 day moving average price is $16.78. The firm has a market capitalization of $2.35 billion, a PE ratio of -70.05, a price-to-earnings-growth ratio of 1.15 and a beta of 1.51. The company has a debt-to-equity ratio ...Real time Certara (CERT) stock price quote, stock graph, news & analysis. A. The latest price target for Certara ( NASDAQ: CERT) was reported by Stephens & Co. on Wednesday, October 11, 2023. The analyst firm set a price target for 20.00 expecting CERT to rise to within ...William Blair Investment Management LLC grew its position in shares of Certara, Inc. (NASDAQ:CERT - Free Report) by 4.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,026,786 shares of the company's sNov 23, 2023 · Latest Software and Certara Inc, Blackbaud Inc Stock News. As of November 22, 2023, Certara Inc had a $2.3 billion market capitalization, compared to the Software median of $426.2 million. Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price ...

Arena Pharmaceuticals. 22-Feb-1999. Later Stage VC. 0000. Completed. 5 buyers. To view Certara’s complete exits history, request access ». Information on stock, financials, earnings, subsidiaries, investors, and executives for Certara. Use the PitchBook Platform to explore the full profile. Arena Pharmaceuticals. 22-Feb-1999. Later Stage VC. 0000. Completed. 5 buyers. To view Certara’s complete exits history, request access ». Information on stock, financials, earnings, subsidiaries, investors, and executives for Certara. Use the PitchBook Platform to explore the full profile.We would like to show you a description here but the site won’t allow us.The estimated Net Worth of William F Feehery is at least $75.5 million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $42,281,189 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Key Insights Using the 2 Stage Free Cash Flow to Equity, Certara fair value estimate is US$18.83 Certara is estimated... Find the latest Certara, Inc. (CERT) stock quote, history, news and other vital information to help you with your stock trading and investing. Ms Sherman CERT stock SEC Form 4 insiders trading. Ms has made over 1 trades of the Certara stock since 2023, according to the Form 4 filled with the SEC. Most recently she exercised 3,990 units of CERT stock worth $50,194 on 31 March 2023.. The largest trade she's ever made was exercising 3,990 units of Certara stock on 31 March …

Rajesh Krishna, PhD, is a Distinguished Scientist in Drug Development Science and lead of the integrated practice area on rare diseases at Certara Strategic Consulting. With ~25 years of combined pharmaceutical industry and consulting experience, he has contributed to over 40 INDs; over 200 Phase 1/1b studies; and to several …

The estimated Net Worth of Richard M. Traynor is at least $9.96 Million dollars as of 6 March 2023. Mr Traynor owns over 10,000 units of Certara stock worth over $4,353,865 and over the last 2 years he sold CERT stock worth over $5,603,360.Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock ...A high-level overview of Twilio Inc. (TWLO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Certara stock drops after biotech software company misses profit target. Certara Inc. CERT, -2.56% stock was down 14.6% in premarket trades on Thursday …Mar 22, 2023 · Reiterating 2023 Financial Outlook. Certara continues to expect the following: Full year 2023 revenue to be in the range of $370 million to $385 million. Full year 2023 adjusted EBITDA to be in the range of $131 million to $137 million. Full year adjusted diluted earnings per share to be in the range of $0.50 - $0.55. With a price of $14.6 and a GuruFocus Value of $25.18, the stock has a price-to-GF-Value ratio of 0.58. Story continues Insider Sell: Leif Pedersen Sells 51,224 Shares of Certara Inc (CERT)CERT Stock Overview. Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. About the company. CERT fundamental analysis. Snowflake Score. Valuation. 1 /6. Future Growth.

With a price of $14.6 and a GuruFocus Value of $25.18, the stock has a price-to-GF-Value ratio of 0.58. Story continues Insider Sell: Leif Pedersen Sells 51,224 Shares of Certara Inc (CERT)

Nov 21, 2023 · Certara Stock Performance. Certara stock opened at $14.71 on Tuesday. The stock’s 50 day moving average price is $13.73 and its 200 day moving average price is $16.78. The firm has a market capitalization of $2.35 billion, a PE ratio of -70.05, a price-to-earnings-growth ratio of 1.15 and a beta of 1.51. The company has a debt-to-equity ratio ...

Inclisiran is a novel N-acetylgalactosamine (GalNAc) conjugated small-interfering ribonucleic acid (siRNA) therapy designed to specifically target proprotein convertase subtilisin/kexin type 9 (PCSK9) mRNA in the liver for the treatment of hypercholesterolemia.Exhibit 10.21 . CERTARA, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN . 1. Purpose.The purpose of the Plan is to provide a means by which Eligible Employees may purchase Common Stock, thereby strengthening their commitment to the welfare of the Company and its Designated Companies and aligning their interests with those of the …TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comThe estimated Net Worth of William F Feehery is at least $78.7 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $45,530,211 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.22 Nov 2023 ... Certara accelerates medicines to patients using proprietary biosimulation ... Share. Save. Report. Comments. thumbnail-image. Add a comment...Get Certara alerts: Insider Activity at Certara. In other Certara news, major shareholder Avatar Parent L.P. Eqt sold 1,500,000 shares of the company's stock in a transaction dated Tuesday, May 31st. The stock was sold at an average price of $19.00, for a total value of $28,500,000.00.Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.Mar 24, 2021 · Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (“the selling stockholders”) at a price to the public of $25.00 per share. Additionally, the selling stockholders have granted the ...

Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private EquityPRINCETON, N.J., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today ...Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development. In some cases, we can eliminate certain human trials completely. More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services.Principal Financial Group Inc. lowered its stake in shares of Certara, Inc. (NASDAQ:CERT – Free Report) by 5.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 600,624 shares of the company’s stock after selling 36,064 …110 Salaries (for 72 job titles) • Updated Nov 20, 2023. How much do Certara employees make? Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. Our model gets smarter over time as more people share …Instagram:https://instagram. value of 1964 kennedy half dollarmovie trailers applehow to buy stocks on webullclearsign PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8th, 2023. Company management will host a conference call to discuss financial results at 5:00PM ET.Get the latest information on Certara, Inc. (CERT) stock, including its performance, outlook, earnings, dividends, and insider transactions. See how CERT stock compares to other medical AI companies and the healthcare industry. is plug power a buyvz stock dividends You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading. jnj exchange offer When is Certara (NASDAQ:CERT) reporting earnings? A. Certara ( CERT) is scheduled to report earnings on February 28, 2024. The last reported earnings were for reported on November 8, 2023 for Q3. Q.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.Dr Feehery owns over 36,580 units of Certara stock worth over $42,522,670 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara. Wallmine is a …